SCHEMBL9911355

SCHEMBL9911355

CC(C)NCc1cccc[n+]1[O-]

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
KMT2A Q03164 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HRH1 P35367 1/20 0.37
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
ADRB2 P07550 1/20 0.34
ADRB1 P08588 1/20 0.34
BCHE P06276 1/20 0.34
ACHE P22303 1/20 0.34
SLC2A1 P11166 1/20 0.32
KDM4E B2RXH2 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
CNR1 P21554 1/20 0.31
HTR2C P28335 1/20 0.31
MAP3K8 P41279 2/20 0.31
EGFR P00533 1/20 0.31
CYP3A4 P08684 1/20 0.31
MAPKAPK2 P49137 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9911344 0.82 ALDH1A1 (0.42) ALDH1A1KMT2AL3MBTL1LMNAHTT
SCHEMBL6808561 0.76 ALDH1A1 (0.46) ALDH1A1KMT2AL3MBTL1LMNAHTT
SCHEMBL9911360 0.75 ALDH1A1 (0.44) ALDH1A1KMT2AL3MBTL1LMNAHTT
SCHEMBL9297535 0.71 NPSR1 (0.43) ALDH1A1KMT2AL3MBTL1SLC2A1KDM4E
SCHEMBL696060 0.71
SCHEMBL29457179 0.71
SCHEMBL929210 0.70 ALDH1A1 (0.41) ALDH1A1KMT2AL3MBTL1LMNAHTT
SCHEMBL3070131 0.70 ALDH1A1 (0.45) ALDH1A1LMNAHTTSLC2A1KDM4E
SCHEMBL904632 0.69
SCHEMBL6357879 0.68 ALDH1A1 (0.46) ALDH1A1KMT2AL3MBTL1LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8198458-B2 Non-nucleoside reverse transcriptase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-12 US disclosed
US-20090143370-A1 Non-nucleoside Reverse Transcriptase Inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-06-04 US disclosed
US-7517998-B2 Benzothiazole or benzothiazine derivative of dipyrido(2,3;b:2',3'-e) diazepin-6-one; viricide against human t-cell leukemia/lymphoma virus BOEHRINGER INGELHEIM INTERNATIONAL GMBH 2009-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143370-A1 Non-nucleoside Reverse Transcriptase Inhibitors RTF1, POLR1A, POLR1E ALDH1A1 411/4885KMT2A 1509/4885L3MBTL1 1499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.